387 related articles for article (PubMed ID: 22213684)
21. Current role of LC-MS(/MS) in doping control.
Thevis M; Thomas A; Schänzer W
Anal Bioanal Chem; 2011 Aug; 401(2):405-20. PubMed ID: 21424519
[TBL] [Abstract][Full Text] [Related]
22. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
Görgens C; Guddat S; Orlovius AK; Sigmund G; Thomas A; Thevis M; Schänzer W
Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
[TBL] [Abstract][Full Text] [Related]
23. Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control.
Mazzarino M; de la Torre X; Botrè F
Anal Bioanal Chem; 2011 Aug; 401(2):529-41. PubMed ID: 21380606
[TBL] [Abstract][Full Text] [Related]
24. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
25. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
26. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
27. Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing.
Thevis M; Krug O; Schänzer W
Rapid Commun Mass Spectrom; 2013 May; 27(9):993-1004. PubMed ID: 23592202
[TBL] [Abstract][Full Text] [Related]
28. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous identification of prednisolone and its ten metabolites in human urine by high performance liquid chromatography-tandem mass spectrometry.
Ahi S; Beotra A; Dubey S; Upadhyay A; Jain S
Drug Test Anal; 2012 Jun; 4(6):460-7. PubMed ID: 22354815
[TBL] [Abstract][Full Text] [Related]
30. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.
Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes.
Beuck S; Schänzer W; Thevis M
J Mass Spectrom; 2011 Feb; 46(2):112-30. PubMed ID: 21254313
[TBL] [Abstract][Full Text] [Related]
32. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing.
Tretzel L; Thomas A; Piper T; Hedeland M; Geyer H; Schänzer W; Thevis M
J Pharm Biomed Anal; 2016 May; 123():132-40. PubMed ID: 26896632
[TBL] [Abstract][Full Text] [Related]
33. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
34. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.
Thevis M; Sigmund G; Thomas A; Gougoulidis V; Rodchenkov G; Schänzer W
Eur J Mass Spectrom (Chichester); 2009; 15(4):507-15. PubMed ID: 19661559
[TBL] [Abstract][Full Text] [Related]
35. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
Balcells G; Matabosch X; Ventura R
Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.
Hansson A; Thevis M; Cox H; Miller G; Eichner D; Bondesson U; Hedeland M
J Pharm Biomed Anal; 2017 Feb; 134():228-236. PubMed ID: 27918992
[TBL] [Abstract][Full Text] [Related]
37. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
[TBL] [Abstract][Full Text] [Related]
38. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
[TBL] [Abstract][Full Text] [Related]
39. Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.
Balcells G; Gómez C; Garrostas L; Pozo ÓJ; Ventura R
Drug Test Anal; 2017 Jul; 9(7):983-993. PubMed ID: 27686240
[TBL] [Abstract][Full Text] [Related]
40. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
